These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4124339)

  • 1. [Method of determining total antithrombin activity, antithrombins II, 3 and IV].
    Babich VP; Byshevskii ASh
    Lab Delo; 1972; 8():467-70. PubMed ID: 4124339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of new methods for studies in the area of blood coagulation. 3. Gel diffusion test for quantitative determination of total antithrombin capacity of plasma].
    Doleschel W
    Wien Med Wochenschr; 1972 Oct; 122(42):601-6. PubMed ID: 4628200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmatic antithrombin activity in multiple myeloma].
    Nenci GG; Notaristefano A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1389-91. PubMed ID: 5398278
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].
    Goldstein C; Sumoza A; De Bosch N; De Sanz N
    Sangre (Barc); 1973; 18(3):313-21. PubMed ID: 4757640
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of Normotest and antithrombin 3 in the assessment of liver function.
    Mannucci L; Dioguardi N; Del Ninno E; Mannucci PM
    Scand J Gastroenterol Suppl; 1973; 19():103-7. PubMed ID: 4515631
    [No Abstract]   [Full Text] [Related]  

  • 6. A method for the differential determination of plasma antithrombins.
    Musumeci V; Vincenti A; Bizzi B
    J Clin Pathol; 1976 Jan; 29(1):63-8. PubMed ID: 55420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin I effect of fibrin].
    Dolesobel W
    Wien Med Wochenschr; 1972 Oct; 122(41):585-90. PubMed ID: 4628353
    [No Abstract]   [Full Text] [Related]  

  • 8. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3].
    Fujimaki M; Nagasawa H
    Nihon Rinsho; 1974 May; 32(5):942-7. PubMed ID: 4211348
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and low antithrombin-3 activity.
    von Kaulla E; von Kaulla KN
    Lancet; 1970 Jan; 1(7636):36. PubMed ID: 4188357
    [No Abstract]   [Full Text] [Related]  

  • 11. Standardisation of a simple method for the determination of antithrombin activity.
    Frigola A
    J Clin Pathol; 1977 Sep; 30(9):881-3. PubMed ID: 915017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin activity of serum from the native or recalcified blood.
    Gaertner HA; Okulski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):454-8. PubMed ID: 4168281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercalcemia and antithrombin activity in a case of IgA myeloma].
    Baele G; Lameire N
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1444-50. PubMed ID: 5069831
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative determination of total antithrombin 3 in plasma.
    Yue RH; Starr T; Gertler MM
    Thromb Diath Haemorrh; 1973 Sep; 30(1):84-92. PubMed ID: 4788755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
    Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
    Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in antithrombin 3 levels following cessation of anticoagulant therapy.
    Refvem O; Fagerhol MK; Abildgaard U
    Acta Med Scand; 1973 Apr; 193(4):307-9. PubMed ID: 4197871
    [No Abstract]   [Full Text] [Related]  

  • 18. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of methods of determining the activity of progressively acting blood anticoagulants].
    Barkagan LZ; Bishevskiĭ KM; Arkhipov BF
    Lab Delo; 1981; (9):544-7. PubMed ID: 6169943
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of depressed antithrombin-3 activity associated with oral contraceptives.
    Zuck TF; Bergin JJ; Raymond JM; Dwyre WR
    Surg Gynecol Obstet; 1971 Oct; 133(4):609-12. PubMed ID: 5096309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.